Argenx Launches Phase I/II Study of ARGX-110 in Combination with Azacitidine Pharmaceutical Investing
Naturally Splendid Director and President of the Canadian Hemp Trade Alliance Interviewed on BNN Company News
Genticel Reports Final Results of GTL001 Phase 2 Trial in HPV16/18-Infected Women Life Science Investing
FDA Clears Integration Between LifeScan's OneTouch Verio Flex Blood Glucose Monitoring System and WellDoc's BlueStar Diabetes Management Platform Medical Device Investing
Bayer Announces FDA Acceptance of Supplemental Biologics License Application for myBETAapp™ and BETACONNECT™ Navigator Pharmaceutical Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
